Literature DB >> 17294353

How to protect from contrast media-induced nephropathy?

B Scheller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17294353     DOI： 10.1007/s00392-007-0486-z

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  44 in total

1.  Effect of X-ray contrast media on blood flow properties after coronary angiography.

Authors:  B Scheller; B Hennen; T Thünenkötter; C Mrowietz; T Markwirth; H Schieffer; F Jung
Journal:  Thromb Res       Date:  1999-11-15       Impact factor: 3.944

2.  Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization.

Authors:  A G Sutton; P Finn; E D Grech; J A Hall; M J Stewart; A Davies; M A de Belder
Journal:  Am Heart J       Date:  2001-04       Impact factor: 4.749

3.  Acute and subacute stent occlusion; risk-reduction by ionic contrast media.

Authors:  B Scheller; B Hennen; A Pohl; H Schieffer; T Markwirth
Journal:  Eur Heart J       Date:  2001-03       Impact factor: 29.983

4.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Authors:  M Tepel; M van der Giet; C Schwarzfeld; U Laufer; D Liermann; W Zidek
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

5.  Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful.

Authors:  B Vogt; P Ferrari; C Schönholzer; H P Marti; M Mohaupt; M Wiederkehr; C Cereghetti; A Serra; U Huynh-Do; D Uehlinger; F J Frey
Journal:  Am J Med       Date:  2001-12-15       Impact factor: 4.965

6.  A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect.

Authors:  John G Webb; Gordon E Pate; Karin H Humphries; Christopher E Buller; Stephen Shalansky; Ali Al Shamari; Anton Sutander; Tracey Williams; Rebecca S Fox; Adeera Levin
Journal:  Am Heart J       Date:  2004-09       Impact factor: 4.749

7.  Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.

Authors:  J Bradley Oldemeyer; W Paul Biddle; Richard L Wurdeman; Aryan N Mooss; Erica Cichowski; Daniel E Hilleman
Journal:  Am Heart J       Date:  2003-12       Impact factor: 4.749

8.  N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up.

Authors:  Steven E S Miner; Vladimir Dzavik; Phong Nguyen-Ho; Robert Richardson; Jan Mitchell; Deborah Atchison; Peter Seidelin; Paul Daly; John Ross; Peter R McLaughlin; Douglas Ing; Peter Lewycky; Alan Barolet; Leonard Schwartz
Journal:  Am Heart J       Date:  2004-10       Impact factor: 4.749

9.  The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography.

Authors:  Shai Efrati; Victor Dishy; Michael Averbukh; Alex Blatt; Ricardo Krakover; Joshua Weisgarten; Jason D Morrow; Michael C Stein; Ahuva Golik
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

10.  The prevention of radiocontrast-agent-induced nephropathy by hemofiltration.

Authors:  Giancarlo Marenzi; Ivana Marana; Gianfranco Lauri; Emilio Assanelli; Marco Grazi; Jeness Campodonico; Daniela Trabattoni; Franco Fabbiocchi; Piero Montorsi; Antonio L Bartorelli
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245
View more
  3 in total

1.  Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty.

Authors:  Michal Droppa; Steffen Desch; Patrick Blase; Ingo Eitel; Georg Fuernau; Gerhard Schuler; Volker Adams; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2011-06-28       Impact factor: 5.460

2.  Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI.

Authors:  Ingo Wickenbrock; Christian Perings; Petra Maagh; Ivo Quack; Marc van Bracht; Magnus W Prull; Gunnar Plehn; Hans-Joachim Trappe; Axel Meissner
Journal:  Clin Res Cardiol       Date:  2009-10-23       Impact factor: 5.460

3.  Quality control after total arterial revascularisation: multislice computer tomography cannot replace coronary angiography.

Authors:  Malakh Shrestha; Nawid Khaladj; Christoph Bara; Jürgen Weidemann; Michael Maringka; Ruoyu Zhang; Axel Haverich; Christian Hagl
Journal:  Clin Res Cardiol       Date:  2008-01-14       Impact factor: 5.460
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.